Media News

Smartee Hosts Breakthrough GS Mandibular Repositioning Therapy Conference in Singapore

SINGAPORE, Aug. 29, 2024 /PRNewswire/ -- Smartee organized the GS Mandibular Repositioning Therapy Conference in Singapore, gathering top dental professionals from across Singapore, Australia, Malaysia, and the Philippines. The conference was led by orthodontic experts, including Prof. Gang Shen, Chief Orthodontist at Taikang Bybo Dental and Smartee's Chief Scientist in R&D, along with Dr. Jingting Lu, a...

Smartee Showcases Iconic Orthodontic Solutions in Hong Kong, Expands Global Reach

HONG KONG, Aug. 29, 2024 /PRNewswire/ -- Smartee, a leading orthodontic brand with two decades of innovation, recently showcased its iconic orthodontic solutions and products at the 13th Hong Kong International Dental Expo and Symposium (HKIDEAS), further accelerating its global expansion. The Smartee booth attracted numerous industry elites, creating a hub of activity and engagement throughout the event....

LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital

TOKYO, Aug. 29, 2024 /PRNewswire/ -- LOTTE Holdings Co., Ltd. ("LOTTE Holdings") is pleased to announce the establishment of a new Healthcare and Biopharmaceutical Corporate Venture Capital ("CVC") dedicated to investing in biopharmaceuticals and next-generation modalities. LOTTE Holdings establishes a new Healthcare and Biopharmaceutical Corporate Venture Capital LOTTE Group operates under the group...

Necessary Care or Abuse? Unpacking the Reason Behind Overprescription

SINGAPORE, Aug. 29, 2024 /PRNewswire/ -- Have you ever wondered if the ten prescriptions your doctor gave you for a cold are truly necessary? Or is there a more complex issue of abuse happening behind the scenes? Today's Case: Overcharging a 7-Year-Old Somsak (an alias name), a 7-year-old boy from Bangkok developed a fever and cough, he was diagnosed...

Celltrion USA partners with Express Scripts and Cigna Healthcare to expand access to ZYMFENTRA® (infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab on their medical benefit formulary

JERSEY CITY, N.J., Aug. 29, 2024 /PRNewswire/ -- Celltrion USA announced today that it has signed an agreement with Cigna Healthcare, the health benefits provider of the Cigna Group and Express Scripts, the pharmacy benefits services business of the Cigna Group's Evernorth and one of the nation's leading health insurers, that will...

Innovent to Present Clinical Data of Multiple Novel Molecules at WCLC and ESMO 2024

SAN FRANCISCO and SUZHOU, China, Aug. 29, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that nearly 20 accepted clinical data of its novel oncology molecules, including six oral presentations, will be...

USANA Achieves HR Asia’s “Best Companies to Work For” Title for Three Consecutive Years

MANILA, Philippines, Aug. 29, 2024 /PRNewswire/ -- USANA Philippines has once again been honored with the prestigious HR Asia Award for being one of the Best Companies to Work For in the Philippines. This marks the third consecutive year the company has received this esteemed recognition, underscoring its commitment to creating a...

iHerb Marks its Commitment to Global Health and Wellness with 28th Anniversary Sales Event

Month-Long Promotions Commemorate Company's Roots as a Small California Startup to a Thriving Global E-commerce Retailer IRVINE, Calif., Aug. 29, 2024 /PRNewswire/ -- iHerb, one of the world's leading online retailers for vitamins, minerals, supplements and other health and wellness products, is proud to celebrate its 28th anniversary with its biggest, month-long September sales event that invites customers to discover daily deals and weekly...

Odie’s Oil Introduces Free Handbook of Toxic Finish Coatings for Finishers & Specifiers

TALLAHASSEE, Fla., Aug. 29, 2024 /PRNewswire/ -- Public Service Announcement Wood finishes, concrete finishes, and other finish coatings are more often than not - laden with toxic chemicals. Coming into physical contact including skin contact, accidental ingestion, or inhalation of these materials that contain certain ingredients can cause serious and often irreversible...

Akeso’s 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization

Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS, and is also the only study to achieve the primary endpoint while showing a positive trend in OS benefit; HARMONi-A study presented in an oral presentation at ASCO 2024 and published in JAMA. Ivonescimab...